Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chemotherapy
Research
Psilocybin proves promising in neuropathic pain mouse study
Giving psilocybin prior to chemotherapy prevented the development of pain hypersensitivity, with protection maintained up to 8 months in mice.
Marissa Russo
Sep 3, 2026 2:00pm
Cabaletta's CAR-T wipes out B cells with no preconditioning
Oct 10, 2025 11:11am
OSE shares 65% OS rate behind cancer vaccine's phase 2 win
Jun 3, 2025 7:05am
Corcept's phase 3 cancer win sends stock skyrocketing 85%
Mar 31, 2025 10:25am
Boston Scientific to buy chemo pump implant for liver tumors
Nov 25, 2024 12:00pm
Approved IBS drug may help overcome prostate cancer resistance
Jan 22, 2024 11:00am
